Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease-Reference-Cited by-同舟云学术

Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease

Published:2016-10-31 Issue:4 Volume:7 Page:621-639
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Zonszein Joel,Groop Per-Henrik

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-016-0208-5.pdf

Reference90 articles.

1. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–9.

2. Centers for Disease Control. Diabetes Report Card. 2014. http://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2014.pdf . Accessed 25 Aug 2015.

3. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med. 2013;368(17):1613–24.

4. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411–7.

5. Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355(23):2427–43.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Pre-operative Insulin Dose to Predict Diabetes Remission After Roux-En-Y Gastric Bypass and Sleeve Gastrectomy;Surgical Innovation;2024-08-06

2. A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant;Molecules;2023-01-29

3. Upregulation of GLUT4 and PI3K, and downregulation of GSK3 mediate the anti‑hyperglycemic effects of proanthocyanidins;Medicine International;2022-04-11

4. Use of SGLT2 inhibitor/metformin fixed dose combination in Korea;Korean Journal of Clinical Pharmacy;2022-03-31

5. Outpatient Management of Type 2 Diabetes Mellitus;A Case-Based Guide to Clinical Endocrinology;2022